Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study

被引:38
作者
Visser, G. H. A. [1 ]
Bilardo, C. M. [2 ]
Derks, J. B. [1 ]
Ferrazzi, E. [3 ]
Fratelli, N. [4 ]
Frusca, T. [5 ]
Ganzevoort, W. [6 ]
Lees, C. C. [7 ,8 ]
Napolitano, R. [9 ]
Todros, T. [10 ]
Wolf, H. [6 ]
Hecher, K. [11 ]
机构
[1] Univ Med Ctr, Dept Perinatol, Utrecht, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands
[3] Univ Milan, Buzzi Childrens Hosp, Dept Woman Mother & Neonate, Milan, Italy
[4] Univ Brescia, Maternal Fetal Med Unit, Brescia, Italy
[5] Univ Hosp, Dept Obstet & Gynecol, Parma, Italy
[6] Acad Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands
[7] Imperial Coll London, Dept Surg & Canc, London, England
[8] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[9] Univ Federico II Naples, Dept Gynecol & Obstet, Naples, Italy
[10] St Anna Hosp, Dept Obstet & Gynecol, Turin, Italy
[11] Univ Med Ctr Hamburg Eppendorf, Dept Obstet & Fetal Med, Hamburg, Germany
关键词
cardiotocography; ductus venosus; fetal growth restriction; fetal heart rate variation; preterm delivery; HEART-RATE-VARIABILITY; RETARDED FETUSES; BETAMETHASONE; DEXAMETHASONE; TRIAL; FLOW;
D O I
10.1002/uog.17361
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective In the TRUFFLE (Trial of Randomized Umbilical and Fetal Flow in Europe) study on the outcome of early fetal growth restriction, women were allocated to one of three groups of indication for delivery according to the following monitoring strategies: (1) reduced fetal heart rate (FHR) short-term variation (STV) on cardiotocography (CTG); (2) early changes in fetal ductus venosus (DV) waveform (DV-p95); and (3) late changes in fetal DV waveform (DV-no-A). However, many infants per monitoring protocol were delivered because of safety-net criteria, for maternal or other fetal indications, or after 32 weeks of gestation when the protocol was no longer applied. The objective of the present posthoc subanalysis was to investigate the indications for delivery in relation to 2-year outcome in infants delivered before 32 weeks to further refine management proposals. Methods We included all 310 cases of the TRUFFLE study with known outcome at 2 years' corrected age and seven fetal deaths, excluding seven cases with inevitable perinatal death. Data were analyzed according to the allocated fetal monitoring strategy in combination with the indication for delivery. Results Overall, only 32% of liveborn infants were delivered according to the specified monitoring parameter for indication for delivery; 38% were delivered because of safety-net criteria, 15% for other fetal reasons and 15% for maternal reasons. In the CTG-STV group, 51% of infants were delivered because of reduced STV. In the DV-p95 group, 34% of infants were delivered because of abnormal DV and, in the DV-no-A group, only 10% of infants were delivered accordingly. The majority of infants in the DV groups were delivered for the safety-net criterion of spontaneous decelerations in FHR. Two-year intact survival was highest in the DV groups combined compared with the CTG-STV group (P=0.05 for live births only, P=0.21 including fetal death), with no difference between DV groups. A poorer outcome in the CTG-STV group was restricted to infants delivered because of FHR decelerations in the safety-net subgroup. Infants delivered because of maternal reasons had the highest birth weight and a non-significantly higher intact survival. Conclusions In this subanalysis of infants delivered before 32 weeks, the majority were delivered for reasons other than the allocated monitoring strategy indication. Since, in the DV group, CTG-STV criteria were used as a safety net but in the CTG-STV group, no DV safety-net criteria were applied, we speculate that the slightly poorer outcome in the CTG-STV group might be explained by the absence of DV data. The optimal timing of delivery of fetuses with early intrauterine growth restriction may therefore be best determined by monitoring them longitudinally, with both DV and CTG monitoring. Copyright (C) 2016 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 16 条
  • [1] Predictors of neonatal outcome in early-onset placental dysfunction
    Baschat, Ahmet A.
    Cosmi, Erich
    Bilardo, Catarina M.
    Wolf, Hans
    Berg, Christoph
    Rigano, Serena
    Germer, Ute
    Moyano, Dolores
    Turan, Sifa
    Hartung, John
    Bhide, Amarnath
    Muller, Thomas
    Bower, Sarah
    Nicolaides, Kypros H.
    Thilaganathan, Baskaran
    Gembruch, Ulrich
    Ferrazzi, Enrico
    Hecher, Kurt
    Galan, Henry L.
    Harman, Chris R.
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (02) : 253 - 261
  • [2] DAWES GS, 1992, OBSTET GYNECOL, V80, P673
  • [3] Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus
    Ferrazzi, E
    Bozzo, M
    Rigano, S
    Bellotti, M
    Morabito, A
    Pardi, G
    Battaglia, FC
    Galan, HL
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2002, 19 (02) : 140 - 146
  • [4] Effect of betamethasone on computerized cardiotocographic parameters in preterm growth- restricted fetuses with and without cerebral vasodilation
    Frusca, T
    Soregaroli, M
    Valcamonico, A
    Scalvi, L
    Bonera, R
    Bianchi, U
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (03) : 194 - 197
  • [5] Monitoring of fetuses with intrauterine growth restriction:: a longitudinal study
    Hecher, K
    Bilardo, CM
    Stigter, RH
    Ville, Y
    Hackelöer, BJ
    Kok, HJ
    Senat, MV
    Visser, GHA
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) : 564 - 570
  • [6] EFFECT OF MAGNESIUM ON FETAL HEART-RATE-VARIABILITY USING COMPUTER-ANALYSIS
    HIETT, AK
    DEVOE, LD
    BROWN, HL
    WATSON, J
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 1995, 12 (04) : 259 - 261
  • [7] Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
    Lees, C.
    Marlow, N.
    Arabin, B.
    Bilardo, C. M.
    Brezinka, C.
    Derks, J. B.
    Duvekot, J.
    Frusca, T.
    Diemert, A.
    Ferrazzi, E.
    Ganzevoort, W.
    Hecher, K.
    Martinelli, P.
    Ostermayer, E.
    Papageorghiou, A. T.
    Schlembach, D.
    Schneider, K. T. M.
    Thilaganathan, B.
    Todros, T.
    van Wassenaer-Leemhuis, A.
    Valcamonico, A.
    Visser, G. H. A.
    Wolf, H.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (04) : 400 - 408
  • [8] 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
    Lees, Christoph C.
    Marlow, Neil
    van Wassenaer-Leemhuis, Aleid
    Arabin, Birgit
    Bilardo, Caterina M.
    Brezinka, Christoph
    Calvert, Sandra
    Derks, Jan B.
    Diemert, Anke
    Duvekot, Johannes J.
    Ferrazzi, Enrico
    Frusca, Tiziana
    Ganzevoort, Wessel
    Hecher, Kurt
    Martinelli, Pasquale
    Ostermayer, Eva
    Papageorghiou, Aris T.
    Schlembach, Dietmar
    Schneider, K. T. M.
    Thilaganathan, Baskaran
    Todros, Tullia
    Valcamonico, Adriana
    Visser, Gerard H. A.
    Wolf, Hans
    [J]. LANCET, 2015, 385 (9983) : 2162 - 2172
  • [9] Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone
    Mulder, EJH
    Derks, JB
    Visser, GHA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (11): : 1239 - 1247
  • [10] Effect of antenatal betamethasone and dexamethasone administration on fetal heart rate variability in growth-retarded fetuses
    Multon, O
    Senat, MV
    Minoui, S
    Hue, MV
    Frydman, R
    Ville, Y
    [J]. FETAL DIAGNOSIS AND THERAPY, 1997, 12 (03) : 170 - 177